BOSS
510(k) K223700Ref Not ApplicableModel BOSS
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK223700 | Date16 Aug 2024 | StatusActive |
| European Union | CE/MDR EUDAMED | Number860006306BOSS98 00860003630631 | Date14 Mar 2023 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Recalls
No FDA recalls found in the data synced 25 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Model / Reference
- BOSS, Not Applicable
- Primary DI / UDI-DI
- 00860003630631
- Basic UDI-DI
- 860006306BOSS98
- Direct Marketing DI
- 00860003630631
- 510(k) Number
- FDA Product Code
- MXK
- EMDN Code
- Q0299 Ophthalmic devices - other
- Device Class
- Class I EUDAMEDClass II 510(k)
- Regulation
- 21 CFR Part 886.1850
- EU market of registration
- Austria
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Truth per registry
| Field | EUDAMED | 510(k) |
|---|---|---|
| Device Class | Class I | Class II |
Overview
AI-generated summary, 18 Sep 2026
The BOSS is a diagnostic device classified under the Anterior Segment Analysis category, designed for ophthalmic applications. It provides detailed imaging and measurement capabilities for assessing corneal and anterior segment structures, aiding in the evaluation of conditions such as keratoconus, corneal dystrophies, and post-surgical assessments.
The BOSS is supplied as a reusable medical device, intended for use in clinical settings such as ophthalmology clinics and hospitals. It is regulated under FDA 510K and MDR compliance, with a Class II designation. The device requires proper sterilization and maintenance as per manufacturer guidelines, and its use is governed by the specified regulatory authorizations.
Other devices from Intelon Optics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What clinical conditions can the BOSS diagnostic device help evaluate in ophthalmology?
The BOSS is designed for detailed imaging and measurement of corneal and anterior segment structures, making it useful for assessing conditions like keratoconus, corneal dystrophies, and post-surgical evaluations. Its anterior segment analysis capabilities allow clinicians to monitor structural changes and diagnose abnormalities in these areas.
Is the BOSS intended for single-use or reusable clinical settings, and what maintenance is required?
The BOSS is supplied as a reusable medical device, intended for use in clinical settings such as ophthalmology clinics and hospitals. Since it is reusable, proper sterilization and maintenance are required as per the manufacturer’s guidelines to ensure safety and functionality between uses.
How is the regulatory status of the BOSS defined, and what does this mean for clinicians?
The BOSS holds FDA 510K clearance and MDR compliance, with a Class II designation. This means it has undergone regulatory review to demonstrate substantial equivalence to a predicate device, ensuring it meets safety and performance standards for clinical use in ophthalmology. Clinicians can rely on its compliance with these regulatory frameworks.
What types of facilities or settings is the BOSS intended for, and why?
The BOSS is specifically designed for clinical settings such as ophthalmology clinics and hospitals. Its advanced imaging and measurement capabilities for corneal and anterior segment analysis require controlled environments where precise diagnostics are performed, ensuring accurate assessments for patient care.
Properties
Other properties (13)
- Sterile: No
- Implantable: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No